Mice with targeted mutations in genes required for Notch signal transduction die during embryogenesis, displaying overt signs of hemorrhage due to defects in their vascular development. Surprisingly, directed expression of a constitutively active form of Notch4 within mouse endothelial cells produces a similar vascular embryonic lethality. Moreover, patients with mutations in Notch3 exhibit the cerebral vascular disorder, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). These findings underscore the importance of Notch signaling in vascular development; however, they do not identify the specific functional defect. Here, we report that Notch1, Notch3, Notch4, Delta4, Jagged1 and Jagged2 are all expressed in arteries, but are not expressed by veins. These findings identify an aspect of Notch signaling that could contribute to the mechanism by which this pathway modulates vascular morphogenesis. q
Results and discussion
Evidence from a number of studies has indicated a role for Notch signaling during vasculature development as well as maintenance of vessel homeostasis in the adult (reviewed in Gridley, 2001) . Both increases and decreases in Notch signaling in mice produce similar vascular phenotypes, suggesting that the level of signaling is critical for proper blood vessel development. Specifically, alterations in Notch signaling produce abnormalities in vessel structure, branching and patterning of the vasculature indicative of defects in angiogenic remodeling. The presence of a malformed vasculature suggests that Notch signaling does not function early in vasculogenesis, but rather regulates subsequent remodeling events that pattern the vascular network. Although a number of studies with various vertebrates have identified the expression of Notch pathway genes in developing blood vessels (Beckers et al., 1999; del Amo et al., 1992; Jones et al., 2000; Joutel et al., 2000; Leimeister et al., 2000; Luo et al., 1997; Myat et al., 1996; Post et al., 2000; Shutter et al., 2000; Uyttendaele et al., 1996; Vargesson et al., 1998) , no one study has comprehensively examined the expression of all known ligands and receptors in the developing vasculature. To this end, we have examined the expression of four Notch receptors (Notch1-4) and five Notch ligands (Delta1, 3 and 4; Jagged1 and 2) throughout embryonic (E) development (stages E10-E17) and present here data from E13.5 as a stage representative of our findings. Specifically, our analysis involved the examination of gene expression within major blood vessels such as the descending aorta, vena cava, cardinal and portal veins, as well as intersomitic, carotid and umbilical arteries and veins, which were identified using both anatomical criteria (Kaufman, 1992) and arterial or venous specific staining with ephrinB2 or EphB4, respectively (Wang et al., 1998) .
In situ hybridization on E13.5 tissue sections revealed a signal for Notch1 in the descending aorta; however, the adjacent vena cava appeared negative (Fig. 1A) . In contrast, a signal for Notch2 was not detected in either arteries or veins ( (01)00469-5 www.elsevier.com/locate/modo specific markers, Notch3 expression has been localized specifically to smooth muscle cells and is absent from endothelial cells (Joutel et al., 2000) , but its restriction to arteries has not been previously noted. The expression of Notch4 has been reported to be endothelium specific (Uyttendaele et al., 1996) . In addition, our analysis indicates that this Notch gene is also selectively expressed in the arterial endothelium, as a signal was not detected in veins (Fig.  1D ). Neither Delta1 (Fig. 1E) nor Delta3 (Fig. 1F ) expression was detected in vessels at this developmental time point, while a signal for Delta4 (Fig. 1G ) was detected only in the arterial endothelium, consistent with previous reports (Shutter et al., 2000) . Both Jagged1 and Jagged2 transcripts were detected in arteries and were absent from veins as shown for the descending aorta and subcardinal vein in Fig. 1H ,I. Our analysis indicates that for the Notch receptors and ligands detected in the developing vasculature (E10-E17), their expression is restricted to arterial blood vessels similar to that previously described for ephrinB2 (Wang et al., 1998 ; Fig. 1J ), in contrast to Flk-1 which is expressed by endothelial cells within both the arterial and venous arms of the vasculature (Brown et al., 1997;  Fig. 1K ).
Jagged1 expression has been reported for the endothelial lining of blood vessels (Myat et al., 1996) , but the signal detected in Fig. 1H suggested that the smooth muscle cells encircling the descending aorta might also express this Notch ligand. Co-staining of tissue sections with antibodies directed to Jagged1 and PECAM (platelet endothelial cell adhesion molecule), a marker of endothelial cells, corroborated Jagged1 endothelial expression ( Fig. 2A-C) . However, costaining with antibodies to Jagged1 and a-smooth muscle actin (SMA) demonstrated that Jagged1 was also expressed by smooth muscle cells (Fig. 2D-F) . Interestingly, Jagged1 expression appears to be specific for arterial smooth muscle cells, as a signal for Jagged1 was not detected in veins (Fig.  1H ) or in the visceral smooth muscle cells that surround the lining of the trachea and esophagus (Fig. 2G,H) . Distinct transcriptional regulatory programs have previously been identified for vascular and visceral smooth muscle cells (Li et al., 1996 ) and Jagged1 appears to be one of these genes. Finally, of all the receptors and ligands examined here, Notch4 is the only receptor and Delta4 is the only Notch ligand expressed in the capillaries (Fig. 2I,J) . The results of this study provide the first evidence for arterial specific expression for receptors and ligands of the Notch signaling pathway during development of the vasculature.
Materials and methods

In situ hybridization
The isolation and preparation of E13.5 embryos and transverse tissue sections for in situ hybridization using digoxigenin-labeled riboprobes has been previously described in detail . The DNA templates used to generate antisense riboprobes have all been previously described and are as follows for Notch1, Notch2, Notch3, Delta1, Delta3, Jagged1 , Jagged2 (Shawber et al., 1996) , Delta4 (Shutter et al., 2000) Notch4 (Uyttendaele et al., 1996) , EphrinB2 (Wang et al., 1998) and Flk1 (Brown et al., 1997) .
Immunohistochemistry
Co-immunolocalization of Jagged1 and PECAM or Jagged1 and smooth muscle actin was performed by coincubation of primary and secondary antibodies conjugated with Texas Red and fluorescein isothiocyanate (FITC). For primary antibodies, anti-Jagged1 (C20, Santa Cruz, CA) was diluted to 1:250, anti-smooth muscle actin was used at 20 mg/ml (Sigma, St. Louis, MO), and anti-PECAM was used at 25 mg/ml (Pharmigen, San Diego, CA). Observation was performed by confocal microscopy on a BioRad MRC1024 (BioRad, Hercules, CA).
